Age-related macular degeneration 3

Common Name(s)

Age-related macular degeneration 3

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Age-related macular degeneration 3" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Age-related macular degeneration 3" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Age-related macular degeneration 3" returned 13 free, full-text research articles on human participants. First 3 results:

Omega-3 supplementation combined with anti-vascular endothelial growth factor lowers vitreal levels of vascular endothelial growth factor in wet age-related macular degeneration.
 

Author(s): Flavio A Rezende, Eric Lapalme, Cynthia X Qian, Lois E Smith, John Paul SanGiovanni, Przemyslaw Sapieha

Journal: Am. J. Ophthalmol.. 2014 Nov;158(5):1071-78.

 

To determine the influence of omega-3 supplementation on vitreous vascular endothelial growth factor A (VEGF-A) levels in patients with exudative age-related macular degeneration (wet AMD) receiving intravitreal anti-VEGF treatment.

Last Updated: 2 Dec 2014

Go To URL
Toll-like receptor 3 polymorphism is not associated with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in the Chinese.
 

Author(s): Y Cheng, M W Li, H P Li, W T Zeng, P Zhou, L Z Huang, X X Li, Y Y Sun

Journal:

 

Toll-like receptor 3 (TLR3) variants in mainland northern Chinese patients with polypoidal choroidal vasculopathy (PCV) and neovascular age-related macular degeneration (nAMD) were investigated. The complete genes of TLR3, including all exons and the promoter region, were assessed ...

Last Updated: 18 Feb 2014

Go To URL
Increase in peripheral blood mononuclear cell Toll-like receptor 2/3 expression and reactivity to their ligands in a cohort of patients with wet age-related macular degeneration.
 

Author(s): Yi Zhu, Liang Liang, Dan Qian, Hongsong Yu, Peizeng Yang, Bo Lei, Hui Peng

Journal:

 

To investigate Toll-like receptor (TLR) expression and reactivity in patients with the wet form age-related macular degeneration (AMD).

Last Updated: 15 Aug 2013

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Age-related macular degeneration 3" returned 1 free, full-text review articles on human participants. First 3 results:

Systematic review and meta-analysis of the association between complement component 3 and age-related macular degeneration: a HuGE review and meta-analysis.
 

Author(s): Ammarin Thakkinstian, Gareth J McKay, Mark McEvoy, Usha Chakravarthy, Subhabrata Chakrabarti, Giuliana Silvestri, Inderjeet Kaur, Xiaoxin Li, John Attia

Journal: Am. J. Epidemiol.. 2011 Jun;173(12):1365-79.

 

The authors performed a meta-analysis to estimate the magnitude of polymorphism effects for the complement component C3 gene (C3) and their possible mode of action on age-related macular degeneration (AMD). The meta-analysis included 16 and 7 studies for rs2230199 and rs1047286, respectively. ...

Last Updated: 7 Jun 2011

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Microperimetry and Eye Progressing From Stage 3 to Stage 4 Age-related Macular Degeneration (AMD)
 

Status: Not yet recruiting

Condition Summary: Stage 3 Age Related Macular Degeneration (AREDS Classification)

 

Last Updated: 23 Mar 2015

Go to URL
Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
 

Status: Recruiting

Condition Summary: Neovascular Age-Related Macular Degeneration

 

Last Updated: 30 Apr 2015

Go to URL
Intravitreal tPA and C3F8 for the Treatment of Submacular Haemorrhage as a Complication of Neovascular Age-related Macular Degeneration
 

Status: Recruiting

Condition Summary: Exudative Macular Degeneration; Retinal Hemorrhage

 

Last Updated: 24 Jun 2014

Go to URL